-
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
-
The Impact of the RACE for Children ActLegislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
-
Making Collaboration More Common for Rare CancersAn AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
by Marci A. Landsmann
-
Second DCIS Diagnoses May Not Be Related to Initial LesionDNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising questions about how to best treat recurrence.
by Eric Fitzsimmons
-
How COVID-19 Changed Cancer CareA new report from the American Association for Cancer Research explores how the COVID-19 pandemic affected cancer patients, researchers and care providers.
by Eric Fitzsimmons
-
Need a Ride?Cancer center expands pilot program to provide transportation for patients to get to appointments.
by Karen Blum
-
Cancer, On and Off StageErin Cronican, who has stage IV breast cancer, plays the lead role of a professor diagnosed with metastatic ovarian cancer in the New York City production of Wit.
by Pamela Rafalow Grossman
-
Acknowledging the Stress of CancerA patient advocate session at the San Antonio Breast Cancer Symposium offered practical tips for dealing with cancer.
by Marci A. Landsmann
-
2021: The Year in Cancer NewsThe Cancer Today editorial staff selects some of the most impactful reporting and essays of 2021.
by Cancer Today Staff
-
Telling Your Children About Your Advanced Cancer DiagnosisProviding age-appropriate information can help children process your diagnosis and ask questions.
by Lorna Collier
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
-
Pediatric Cancer’s AftershocksNew research highlights approaches that could provide better long-term quality of life for childhood cancer survivors.
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
